Skip to main content

Table 4 Antibiotic resistance in Gram-negative isolates of BSI

From: Epidemiology and outcomes of bloodstream infections in severe burn patients: a six-year retrospective study

Antibiotics A. baumannii, % resistant (n = 51) K. pneumoniae, % resistant (n = 41) P. aeruginosa, % resistant (n = 22)
Amikacin 75.0 52.8 45.0
Ceftazidime 95.0 88.9 30.0
Cefepime 95.0 80.6 65.0
Ciprofloxacin 95.0 86.1 50.0
Levofloxacin 72.5 80.6 55.0
Imipenem 95.0 77.8 75.0
Meropenem 95.0 77.8 75.0
Cefoperazone-Sulbactam 72.5 88.9 80.0
Piperacillin-Tazobactam 95.0 80.6 80.0
Tigecycline 11.4 (n = 45) 24.0 (n = 29)
Polymyxin B 0.0 (n = 21) 0.0 (n = 18) 0.0 (n = 9)